Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT) (2019)
- Authors:
- Autor USP: BURDMANN, EMMANUEL DE ALMEIDA - FM
- Unidade: FM
- DOI: 10.1053/j.ajkd.2018.10.006
- Subjects: ANEMIA; ERITROPOIETINA; HEMODIÁLISE; DOENÇAS CARDIOVASCULARES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2019
- Source:
- Título do periódico: American journal of kidney diseases
- ISSN: 0272-6386
- Volume/Número/Paginação/Ano: v. 73, n. 3, p. 309-315, 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
CAUSLAND, Finnian R. Mc et al. Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT). American journal of kidney diseases, v. 73, n. 3, p. 309-315, 2019Tradução . . Disponível em: https://doi.org/10.1053/j.ajkd.2018.10.006. Acesso em: 18 abr. 2024. -
APA
Causland, F. R. M., Claggett, B., Burdmann, E. de A., Chertow, G. M., Cooper, M. E., Eckardt, K. -U., et al. (2019). Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT). American journal of kidney diseases, 73( 3), 309-315. doi:10.1053/j.ajkd.2018.10.006 -
NLM
Causland FRM, Claggett B, Burdmann E de A, Chertow GM, Cooper ME, Eckardt K-U, Ivanovich P, Levey AS, Lewis EF, Mcgill JB. Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT) [Internet]. American journal of kidney diseases. 2019 ; 73( 3): 309-315.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1053/j.ajkd.2018.10.006 -
Vancouver
Causland FRM, Claggett B, Burdmann E de A, Chertow GM, Cooper ME, Eckardt K-U, Ivanovich P, Levey AS, Lewis EF, Mcgill JB. Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT) [Internet]. American journal of kidney diseases. 2019 ; 73( 3): 309-315.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1053/j.ajkd.2018.10.006 - Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
- Extracorporeal Treatment for Lithium Poisoning: systematic Review and Recommendations from the EXTRIP Workgroup
- Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
- Peritoneal Dialysis in Acute Kidney Injury: Lessons Learned and Applied
- Acute kidney injury: global health alert
- Acute kidney injury: global health alert
- Predictive usefulness of unirary biomarkers for the identification of cyclosporine A induced nephrotoxicity in a rat model
- Cyclic Direct Radionuclide Cystography in the Diagnosis and Characterization of Vesicoureteral Reflux in Children and Adults
- Empatia em estudantes de Medicina: efeitos de um programa de gerenciamento do estresse
- Association of magnesium abnormalities at intensive care unit admission with kidney outcomes and mortality: a prospective cohort study
Informações sobre o DOI: 10.1053/j.ajkd.2018.10.006 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
